BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
PDX1
,
nitric oxide metabolic process
,
Influenza
,
Liver
,
DNA fingerprint
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
lys- val
Summary
General Info
Curated Studies
Most Correlated Studies
B cell lymphoma VAL and OCI-LY3 cells treated with CDK-9 inhibitor AZ5576 compound
Explore Curated Studies Results
Literature
Most Relevant Literature
Combination Therapy of Placenta-Derived Mesenchymal Stem Cells with WKYMVm Promotes Hepatic Function…
The effect of the WKYMVm peptide on promoting mBMSC secretion of exosomes to induce M2 macrophage po…
Activation of formyl peptide receptor 1 elicits therapeutic effects against collagen-induced arthrit…
Effects of Formyl Peptide Receptor Agonists Ac9-12 and WKYMV in In Vivo and In Vitro Acute Inflammat…
Formyl Peptide Receptor 2 Alleviates Hepatic Fibrosis in Liver Cirrhosis by Vascular Remodeling.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Gastric Emptying Validation Pilot Study (MRI Val)
Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma
Impact of Educational and Professional Supportive Interventions on Nursing Home Quality Indicators
Treatment of Malignant Vertebral Fractures With Percutaneous Balloon Kyphoplasty.
National Survey on GERD Patients (Adults and Children)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ